Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Murren

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Modulating multidrug resistance: can we target this therapy?John R Murren
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Angiogenesis in non-small cell lung cancer. A new target for therapyTracy E Kim, John R Murren
Idrugs : the Investigational Drugs Journal|September 10, 2003
Lapatinib ditosylate GlaxoSmithKlineTracy E Kim, John R Murren
Current Opinion in Investigational Drugs (London, England : 2000)|December 25, 2002
Erlotinib OSI/Roche/GenentechTracy E Kim, John R Murren
Clinics in Chest Medicine|March 21, 2002
Therapy for stage IIIB and stage IV non-small cell lung cancerTracy E Kim, John R Murren
Critical Reviews in Oncology/Hematology|March 12, 2004
Progress in the therapy of small cell lung cancerMiklos Simon, Athanassios Argiris, John R Murren
Oncology (Williston Park, N.Y.)|October 12, 2002
Camptothecin and taxane regimens for small-cell lung cancerMyron S Kwong, Eric Bleickardt, John R Murren
The Lancet. Oncology|March 3, 2006
Metastatic myoepithelial carcinoma of the vulva treated with carboplatin and paclitaxelVanita Noronha, Dennis L Cooper, Susan A Higgins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501Leora Horn, Suzanne E Dahlberg, Alan B Sandler, et al.
Cancer Biology & Therapy|January 17, 2004
A phase II study of topotecan and cyclophosphamide with G-CSF in patients with advanced small cell lung cancerErole M Hobdy, Eric Kraut, Gregory Masters, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Modulating multidrug resistance: can we target this therapy?John R Murren
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Angiogenesis in non-small cell lung cancer. A new target for therapyTracy E Kim, John R Murren
Idrugs : the Investigational Drugs Journal|September 10, 2003
Lapatinib ditosylate GlaxoSmithKlineTracy E Kim, John R Murren
Current Opinion in Investigational Drugs (London, England : 2000)|December 25, 2002
Erlotinib OSI/Roche/GenentechTracy E Kim, John R Murren
Clinics in Chest Medicine|March 21, 2002
Therapy for stage IIIB and stage IV non-small cell lung cancerTracy E Kim, John R Murren
Critical Reviews in Oncology/Hematology|March 12, 2004
Progress in the therapy of small cell lung cancerMiklos Simon, Athanassios Argiris, John R Murren
Oncology (Williston Park, N.Y.)|October 12, 2002
Camptothecin and taxane regimens for small-cell lung cancerMyron S Kwong, Eric Bleickardt, John R Murren
The Lancet. Oncology|March 3, 2006
Metastatic myoepithelial carcinoma of the vulva treated with carboplatin and paclitaxelVanita Noronha, Dennis L Cooper, Susan A Higgins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501Leora Horn, Suzanne E Dahlberg, Alan B Sandler, et al.
Cancer Biology & Therapy|January 17, 2004
A phase II study of topotecan and cyclophosphamide with G-CSF in patients with advanced small cell lung cancerErole M Hobdy, Eric Kraut, Gregory Masters, et al.
Pageof 2